Lovely catching up with Carsten Niemann on the GLOW study 64-month follow-up: #ibrutinib + #venetoclax outperforms #chlorambucil + #obinutuzumab in elderly/comorbid patients 🩸🔦

Stay tuned for the full video www.vjhemonc.com/event/ash-20... 👀

@ash-hematology.bsky.social #ASH24 #CLL